›› 2013, Vol. 28 ›› Issue (12): 1088-1091.DOI: 10.3969/j.issn.1673-8640.2013.12.006

• Orginal Article • Previous Articles     Next Articles

Research on the expression of peripheral blood mononuclear cell HLA-G in patients with hepatocellular carcinoma

LIU Yang1,HU Mei2,YU Hongbo1,LI Jian1.   

  1. 1. Department of Clinical Laboratory,Hunan Provincial Corps Hospital,Chinese People′s Armed Police Forces,Hunan Changsha 410006,China;2.Department of Biochemistry,Hunan Traditional Chinese Medicine University, Hunan Changsha 410006,China
  • Online:2013-12-01 Published:2013-12-20

Abstract:

Objective  To investigate the expression level of peripheral blood mononuclear cell (PBMC) human leucocyte antigen G (HLA-G) in patients with hepatocellular carcinoma (HCC). Methods  The HLA-G mRNA and HLA-G protein expression levels on PBMC from 38 patients with HCC,25 patients with liver cirrhosis and 40 healthy subjects were determined by reverse transcription-polymerase chain reaction (PCR) and flow cytometry (FCM). Results  The HLA-G mRNA expression rates in HCC group,cirrhosis group and healthy control group were 94.7%,84.0% and 87.5%, respectively,and there was no statistical significance (P=0.359). The HLA-G protein expression rate in HCC group was significantly higher than those in cirrhosis and healthy control groups with statistical significance (P=0.002). In HCC group, the HLA-G protein was mainly expressed on CD4+ cells. Conclusions  The PBMC HLA-G protein expression rate in HCC patients increases,and its mechanism and clinical significance need to be further researched.

Key words: Human leucocyte antigen G, Hepatocellular carcinoma, Peripheral blood mononuclear cell

CLC Number: